Show simple item record

dc.contributor.authorTsolekile, L
dc.contributor.authorKatz, I.T
dc.contributor.authorBogart, L.M
dc.date.accessioned2021-04-19T12:44:21Z
dc.date.available2021-04-19T12:44:21Z
dc.date.issued2021
dc.identifier.citationTsolekile, L. et al. (2021). The treatment ambassador program: a highly acceptable and feasible community-based peer intervention for South Africans living with HIV who delay or discontinue antiretroviral therapy. AIDS and Behavior, 25(4),1129-1143en_US
dc.identifier.issn1090-7165
dc.identifier.uri10.1007/s10461-020-03063-1
dc.identifier.urihttp://hdl.handle.net/10566/6078
dc.description.abstractWe conducted a novel pilot randomized controlled trial of the Treatment Ambassador Program (TAP), an 8-session, peerbased, behavioral intervention for people with HIV (PWH) in South Africa not on antiretroviral therapy (ART). PWH (43 intervention, 41 controls) completed baseline, 3- and 6-month assessments. TAP was highly feasible (90% completion), with peer counselors demonstrating good intervention fdelity. Post-intervention interviews showed high acceptability of TAP and counselors, who supported autonomy, assisted with clinical navigation, and provided psychosocial support. Intentionto-treat analyses indicated increased ART initiation by 3 months in the intervention vs. control arm (12.2% [5/41] vs. 2.3% [1/43], Fisher exact p-value=0.105; Cohen’s h=0.41). Among those previously on ART (of for>6 months), 33.3% initiated ART by 3 months in the intervention vs. 14.3% in the control arm (Cohen’s h=0.45). Results suggest that TAP was highly acceptable and feasible among PWH not on ART.en_US
dc.language.isoenen_US
dc.publisherSpringer Natureen_US
dc.subjectEngagement in careen_US
dc.subjectSouth Africaen_US
dc.subjectART initiationen_US
dc.subjectMotivational interviewingen_US
dc.subjectPeer-based interventionen_US
dc.subjectBehavioral interventionen_US
dc.titleThe treatment ambassador program: a highly acceptable and feasible community-based peer intervention for South Africans living with HIV who delay or discontinue antiretroviral therapyen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record